Treatment and outcomes study for priapism
Part of Kidney & urinary clinical trials.
This study looks at how doctors manage priapism (a painful, unwanted erection that lasts a long time) and how different approaches affect outcomes. It may help improve care for people with priapism by tracking what works best and what to expect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with priapism
- You are able to participate in the study visit(s) and follow-up as required by the team
- You are willing to share your medical history and current symptoms with the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if injections of platelet-rich plasma from cord blood, combined with daily penis stretching, works better than stretching alone to treat Peyronie's disease (curved erections). It may help men with moderate to severe curvature who haven't had prior treatment.
This study tests a new medicine, W2505, to see if it is safe and effective for men with erectile dysfunction. Participation may help you manage your condition and contribute to research.
This study tests an experimental drug called BP1.4979 to see if it can help men with lifelong premature ejaculation (PE) last longer during sex. The trial is for men who have had PE since their first sexual experiences and who typically ejaculate within about 1 minute.
This study looks at men having a standard surgery for an enlarged prostate (TURP) to see how well it works. It helps predict the outcome of the surgery based on your test results and symptoms.
This trial tests if a painless electrical nerve stimulation (TENS) treatment can help men with premature ejaculation last longer and feel more in control. It's for men who have had this condition for at least 6 months and are in a stable relationship.
This study looks at how well surgery works for an enlarged prostate (“benign prostatic hyperplasia”) and which care factors affect results. It may help improve future treatment planning and outcomes for people in Hong Kong.
Hear when a new Priapism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.